Stock Research: ALK-Abelló

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

ALK-Abelló

CPSE:ALK B DK0061802139
75
  • Value
    54
  • Growth
    89
  • Safety
    Safety
    4
  • Combined
    45
  • Sentiment
    99
  • 360° View
    360° View
    75
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

ALK-Abello A/S is a Denmark-based pharmaceutical company specializing in allergy treatment, prevention, and diagnosis. Its main businesses include allergy vaccines (tablet, sublingual, subcutaneous), emergency treatments for anaphylaxis, and allergy diagnostics products like skin-prick tests. The company operates worldwide through subsidiaries, production units, and distributors in countries such as Austria, Canada, France, Italy, the Netherlands, Poland, Spain, Switzerland, the United States, and China. In the last fiscal year, the company had 2753 employees, a market cap of $6128 millions, profits of $493 millions, and revenue of $769 millions.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 75 (better than 75% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock ALK-Abelló are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for ALK-Abelló. The consolidated Growth Rank has a good rank of 89, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 89% of competitors in the same industry. The consolidated Safety Rank at 54 means that the company has a financing structure that is safer than 54% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 99, which means that professional investors are more optimistic about the stock than for 99% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 4, meaning that the share price of ALK-Abelló is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 96% of alternative stocks in the same industry. ...read more

more
Index
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 4-Sep-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
4 1 5 1
Growth
89 86 63 77
Safety
Safety
54 73 64 27
Sentiment
99 70 56 58
360° View
360° View
75 81 41 30
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
97 80 72 55
Opinions Change
50 6 17 50
Pro Holdings
n/a 55 34 30
Market Pulse
89 87 91 79
Sentiment
99 70 56 58
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
4 1 5 1
Growth
89 86 63 77
Safety Safety
54 73 64 27
Combined
45 73 32 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
7 9 12 3
Price vs. Earnings (P/E)
9 7 22 15
Price vs. Book (P/B)
4 1 14 3
Dividend Yield
1 1 1 1
Value
4 1 5 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
79 87 67 65
Profit Growth
79 74 86 96
Capital Growth
74 76 10 11
Stock Returns
71 61 56 72
Growth
89 86 63 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
70 67 70 51
Refinancing
15 25 33 26
Liquidity
76 90 62 34
Safety Safety
54 73 64 27

Similar Stocks

Discover high‑ranked alternatives to ALK-Abelló and broaden your portfolio horizons.

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

Polski Koncern Naftowy ORLEN Spolka Akcyjna

WSE:PKN
Country: Poland
Industry: Oil & Gas Refining
Size: X-Large
Full Stock Analysis

Perrigo

NYSE:PRGO
Country: Ireland
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.